Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Norepinephrine dysfunction in depression.

A Anand1, D S Charney

  • 1Department of Psychiatry, Yale University School of Medicine, New Haven, Conn, USA. amit.anand@yale.edu

The Journal of Clinical Psychiatry
|July 26, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Ethical and legal challenges of integrating artificial intelligence into paediatric surgery.

Annals of the Royal College of Surgeons of England·2026
Same author

Knowledge, awareness and practices regarding human papillomavirus vaccine amongst secondary school girls and mothers in North India.

European journal of obstetrics, gynecology, and reproductive biology·2026
Same author

Maternal risk factors and closure techniques in gastroschisis: a 16-year retrospective review from a UK tertiary centre.

Pediatric surgery international·2025
Same author

From expectations to experiences: a systematic review of patient and public perspectives on robotic surgery.

Journal of robotic surgery·2025
Same author

Talk smart, treat better.

British dental journal·2025
Same author

Induction chemotherapy followed by chemoradiation in locally advanced cervical cancer: Quality of life outcomes of the GCIG INTERLACE trial.

European journal of cancer (Oxford, England : 1990)·2025
Same journal

Major Depressive Disorder and PTSD Treatment Outcome in Interpersonal Psychotherapy and Prolonged Exposure.

The Journal of clinical psychiatry·2026
Same journal

Psychiatrists and Medical Aid in Dying: Entering Uncharted Waters.

The Journal of clinical psychiatry·2026
Same journal

Mind and Metabolism in Crisis: US Mortality Involving Obesity and Psychiatric Disorders-Trends, Disparities, and ARIMA Projections.

The Journal of clinical psychiatry·2026
Same journal

Generative AI for the Clinical Psychopharmacologist: Is It Ready for Prime Time?

The Journal of clinical psychiatry·2026
Same journal

Posttrauma Benzodiazepine Use and Subsequent PTSD: A Population-Wide Analysis Following Extreme Traumatic Exposure.

The Journal of clinical psychiatry·2026
Same journal

The Challenges of PTSD Prevention: Placing Benzodiazepine Use in Context.

The Journal of clinical psychiatry·2026
See all related articles

Understanding the noradrenergic system is key to depression research. This review explores norepinephrine's role in depression and the potential of selective norepinephrine reuptake inhibitors (selective NRIs) for new treatments.

Area of Science:

  • Neuroscience
  • Psychiatry
  • Pharmacology

Background:

  • The noradrenergic neurotransmitter system is central to depression research.
  • Norepinephrine and catecholamine actions are crucial for understanding depression's causes.
  • This knowledge can lead to novel depression treatment strategies.

Purpose of the Study:

  • To review the current understanding of the noradrenergic system in relation to depression.
  • To explore the role of selective norepinephrine reuptake inhibitors (selective NRIs) in treating depression.

Main Methods:

  • Literature review of studies on the noradrenergic system and depression.
  • Analysis of the mechanisms of norepinephrine action.
  • Examination of the efficacy and role of selective NRIs.

Related Experiment Videos

Main Results:

  • Norepinephrine plays a significant role in the neurobiology of depression.
  • Selective NRIs represent a viable therapeutic option for depression management.
  • Further research into catecholamine pathways may reveal new treatment targets.

Conclusions:

  • The noradrenergic system is a critical area for depression research.
  • Selective NRIs offer a valuable approach to treating depression.
  • Understanding synaptic and intracellular catecholamine actions is essential for advancing depression therapeutics.